Table 5.
Demographic and clinical data of 36 primary progressive (PPMS), 119 secondary progressive (SPMS), and 94 relapsing remitting (RRMS) patients.
| PPMS | RRMS | SPMS | Total MS | p Value | |||||
|---|---|---|---|---|---|---|---|---|---|
| N | 36 | 94 | 119 | 249 | |||||
|
Female:
N (%) |
17 * | (47.2) | 65 * | (69.1) | 68 | (57.1) | 150 | (60.2) | * = 0.02 |
|
Age
mean (SD) |
55.8 * | (12.2) | 45.4 *° | (9.7) | 53.7 ° | (12.3) | 50.8 | (12.1) | * < 0.001 °<0.001 |
|
DRB1*15 positive:
N (%) |
7 | (19.4) | 23 | (24.5) | 36 | (30.3) | 66 | (26.5) | ns |
|
disease duration
Years’ median (IQR) |
16.0 ^ | (12.5) | 17.5 ° | (13.0) | 24.0 °^ | (11.8) | 20.0 | (14.0) | ^ < 0.001 ° < 0.001 |
|
Hospitalization
Days’ median (IQR) |
31 | (14.3) | 34 | (13.0) | 35 | (12.5) | 35.0 | (13.0) | ns |
|
Interventions
N (IQR) |
4 | (1.5) | 4 | (2.0) | 4 | (2.0) | 4 | (2.0) | ns |
N: absolute number; IQR: interquartile range; ns: not statistically significant. “*” comparison between PPMS and RRMS, “°” comparison between SPMS and RRMS, “^” comparison between PPMS and SPMS.